Comment

. 2021 Jul;9(7):679-680.

doi: 10.1016/S2213-2600(21)00206-X. Epub 2021 May 5.

An integrated understanding of long-term sequelae after acute COVID-19

Piero L Olliaro¹

Affiliations

Affiliation

¹ ISARIC Global Support Centre-International Severe Acute Respiratory and emerging Infection Consortium; and Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK. Electronic address: piero.olliaro@ndm.ox.ac.uk.

PMID: 33964246
PMCID: PMC8099314
DOI: 10.1016/S2213-2600(21)00206-X

Comment

An integrated understanding of long-term sequelae after acute COVID-19

Piero L Olliaro. Lancet Respir Med. 2021 Jul.

. 2021 Jul;9(7):679-680.

doi: 10.1016/S2213-2600(21)00206-X. Epub 2021 May 5.

Author

Piero L Olliaro¹

Affiliation

¹ ISARIC Global Support Centre-International Severe Acute Respiratory and emerging Infection Consortium; and Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK. Electronic address: piero.olliaro@ndm.ox.ac.uk.

PMID: 33964246
PMCID: PMC8099314
DOI: 10.1016/S2213-2600(21)00206-X

No abstract available

PubMed Disclaimer

Conflict of interest statement

I declare no competing interests. I receive salary support from the UK Foreign, Commonwealth, and Development Office; and Wellcome Trust [215091/Z/18/Z].

Figures

See this image and copyright information in PMC

Comment on

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.
Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, Ni F, Fang S, Lu Y, Ding X, Liu H, Ewing RM, Jones MG, Hu Y, Nie H, Wang Y. Wu X, et al. Lancet Respir Med. 2021 Jul;9(7):747-754. doi: 10.1016/S2213-2600(21)00174-0. Epub 2021 May 5. Lancet Respir Med. 2021. PMID: 33964245 Free PMC article.

Cited by

Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine.
Lo Sasso B, Giglio RV, Vidali M, Scazzone C, Bivona G, Gambino CM, Ciaccio AM, Agnello L, Ciaccio M. Lo Sasso B, et al. Diagnostics (Basel). 2021 Jun 22;11(7):1135. doi: 10.3390/diagnostics11071135. Diagnostics (Basel). 2021. PMID: 34206567 Free PMC article.
Evaluation of the analytical performance of three chemiluminescence serological assays for detecting anti-SARS-CoV-2 antibodies.
Lo Sasso B, Agnello L, Giglio RV, Scazzone C, Massa D, Ciaccio AM, Gambino CM, Vidali M, Ciaccio M. Lo Sasso B, et al. Clin Exp Med. 2023 Aug;23(4):1205-1211. doi: 10.1007/s10238-022-00918-w. Epub 2022 Oct 19. Clin Exp Med. 2023. PMID: 36261740 Free PMC article.
Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways.
Aguilar D, Bosacoma A, Blanco I, Tura-Ceide O, Serrano-Mollar A, Barberà JA, Peinado VI. Aguilar D, et al. Life (Basel). 2022 Jun 14;12(6):887. doi: 10.3390/life12060887. Life (Basel). 2022. PMID: 35743918 Free PMC article.
Impact of timing and combination of different BNT162b2 and ChAdOx1-S COVID-19 basic and booster vaccinations on humoral immunogenicity and reactogenicity in adults.
Dedroogh S, Schmiedl S, Thürmann PA, Graf K, Appelbaum S, Koß R, Theis C, Zia Z, Tebbenjohanns J, Thal SC, Dedroogh M. Dedroogh S, et al. Sci Rep. 2023 Jun 3;13(1):9036. doi: 10.1038/s41598-023-34961-8. Sci Rep. 2023. PMID: 37270632 Free PMC article.
Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine.
Lo Sasso B, Agnello L, Giglio RV, Gambino CM, Ciaccio AM, Vidali M, Ciaccio M. Lo Sasso B, et al. Sci Rep. 2022 May 23;12(1):8679. doi: 10.1038/s41598-022-12750-z. Sci Rep. 2022. PMID: 35606426 Free PMC article.

See all "Cited by" articles

References

1. Carson G. Research priorities for long COVID: refined through an international multi-stakeholder forum. BMC Med. 2021;19:84. - PMC - PubMed
1. National Institute for Health and Care Excellence . National Institute for Health and Care Excellence; London: 2020. COVID-19 rapid guideline: managing the long-term effects of COVID-19. - PubMed
1. Wu X, Liu X, Zhou Y, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021 doi: 10.1016/S2213-2600(21)00174-0. published online May 5. - DOI - PMC - PubMed
1. Truffaut L, Demey L, Bruyneel AV, et al. Post-discharge critical COVID-19 lung function related to severity of radiologic lung involvement at admission. Respir Res. 2021;22:29. - PMC - PubMed
1. Michelen M, Manoharan L, Elkheir N, et al. Characterising long-term COVID-19: a rapid living systematic review. medRxiv. 2020 doi: 10.1101/2020.12.08.20246025. published online Dec 9. (preprint). - DOI

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

An integrated understanding of long-term sequelae after acute COVID-19

Affiliation

An integrated understanding of long-term sequelae after acute COVID-19

Author

Affiliation

Conflict of interest statement

Figures

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical